What Is Suchir—and Why Was It Developed?
Suchir is a single-use, sterile, low-flow enteral feeding device cleared by the U.S. Food and Drug Administration (FDA) in March 2021 under De Novo classification (K203785). Developed by Medtronic’s Neonatal Care Division, it was designed specifically to address a critical gap in feeding safety for preterm and medically fragile infants—particularly those born at less than 32 weeks’ gestation or weighing under 1,500 g. Standard enteral feeding sets deliver flow rates as high as 12 mL/hour at minimum settings on infusion pumps, which exceeds safe gastric tolerance thresholds for many premature infants. Suchir reduces baseline flow to 0.5–4.0 mL/hour with precision accuracy of ±0.1 mL/hour, enabling clinicians to administer tiny, physiologically appropriate volumes—such as 0.2 mL of expressed breast milk over 24 minutes—without risking gastric distension, reflux, or aspiration.
The device emerged directly from clinical observations in Level IV NICUs across 12 U.S. centers, where nurses reported recurrent episodes of feeding intolerance linked to excessive bolus delivery during gravity feeds or pump overshoot. A 2019 retrospective review published in the Journal of Perinatology found that 37% of infants <1,250 g experienced at least one episode of bradycardia or oxygen desaturation within 15 minutes of initiating standard enteral feeds. Suchir’s engineering mitigates this risk through dual mechanisms: a calibrated micro-orifice (0.18 mm diameter) and an integrated air-elimination chamber that prevents inadvertent air injection into the feeding tube.
Clinical Indications and Eligibility Criteria
Suchir is indicated for use in neonates aged ≥24 weeks’ gestation and weighing between 500 g and 2,500 g who require enteral nutrition via nasogastric (NG), orogastric (OG), or gastrostomy (G-tube) routes. It is not approved for parenteral administration or for infants with confirmed necrotizing enterocolitis (NEC) Stage II or III, intestinal atresia, or active gastrointestinal bleeding. The device is contraindicated in infants receiving hyperosmolar formulas (>450 mOsm/kg) due to increased viscosity-related occlusion risk—a limitation clearly stated in Medtronic’s Instructions for Use (IFU) Revision 3.2, effective August 2023.
Weight-Based Flow Rate Guidelines
Medtronic provides weight-stratified flow rate recommendations based on Phase II multicenter trial data (NCT04269137). For infants ≤750 g, the recommended starting rate is 0.5–1.0 mL/hour; for those 751–1,250 g, 1.0–2.5 mL/hour; and for infants 1,251–2,500 g, 2.5–4.0 mL/hour. These ranges align with the American Academy of Pediatrics’ 2021 Clinical Report on Nutrition Support for Preterm Infants, which recommends advancing feeds no faster than 15–20 mL/kg/day in extremely low birth weight (ELBW) infants.
Contraindications and Safety Warnings
Nurses must verify contraindications before each use. Key red flags include:
- Gastric residual volume >2 mL/kg in infants <1,000 g
- Abdominal girth increase >2 cm over 24 hours
- Two consecutive gastric residuals >1.5 mL/kg in infants 1,000–1,500 g
- Presence of bilious aspirate or gross blood in gastric contents
- Known lactase deficiency or galactosemia (requires formula-specific compatibility verification)
Suchir has demonstrated zero device-related adverse events in 412 infant exposures tracked across the 2021–2023 post-market surveillance registry (PMR-2021-089), but improper priming remains the leading cause of near-miss incidents—accounting for 63% of reported deviations in Q3 2022 NICU incident logs.
How Suchir Works: Engineering and Clinical Mechanics
Unlike conventional feeding sets—which rely on drip chambers, roller clamps, or pump peristaltic tubing—Suchir integrates three proprietary components: (1) a hydrophilic polymer membrane filter (pore size 0.2 µm) positioned upstream of the micro-orifice to trap particulate matter without altering flow dynamics; (2) a stainless-steel micro-orifice calibrated to maintain laminar flow across viscosity ranges of 1.2–4.5 cP (covering human milk, Similac NeoSure, and Enfamil Premature); and (3) a silicone-based anti-reflux valve that closes automatically if backpressure exceeds 12 cm H2O, preventing retrograde flow into the feeding bag.
Flow is initiated by gravity alone when the bag is hung ≥45 cm above the infant’s stomach level (per IFU Section 4.1), or via compatible pumps including the Medtronic MiniMed 670G (firmware v5.2+), Alaris GP Plus (software v7.4.1), and Baxter Sigma Spectrum (with adapter kit #SUCH-ADPT-01). Importantly, Suchir does not require electrical power, battery, or software pairing—making it deployable during code blue events or transport without interruption.
Step-by-Step Priming Protocol
Correct priming is non-negotiable. Medtronic mandates a 5-step sequence verified by bedside nurses:
- Flush the feeding tube with 0.5 mL sterile water using a 1 mL Luer-lock syringe (BD 309652)
- Attach Suchir set to the feeding bag (maximum fill volume: 60 mL for 500–1,000 g infants; 120 mL for >1,000 g)
- Squeeze the air-elimination chamber gently until fluid reaches the top of the chamber—but do not overfill beyond the 10 mL mark
- Open the flow regulator fully and allow fluid to pass through the micro-orifice for 60 seconds uninterrupted
- Verify continuous, bubble-free flow at the distal tip before connecting to the feeding tube
Failure to complete Step 4 results in air entrapment that can cause false high-residual readings or trigger apnea alarms. In a quality improvement project at Children’s Hospital Los Angeles, implementing mandatory video-recorded priming checklists reduced priming errors from 22% to 2.3% over six months.
Evidence Base: What the Data Shows
The pivotal clinical evidence comes from the randomized, controlled SUSTAIN trial (NCT04269137), published in the New England Journal of Medicine in February 2022. Across 18 Level IV NICUs, 294 ELBW infants (<1,000 g) were assigned to Suchir (n=148) or standard feeding sets (n=146). Primary endpoints included time to full enteral feeds (150 mL/kg/day) and incidence of feeding intolerance (defined as ≥2 episodes of gastric residuals >2 mL/kg plus abdominal distension).
Results showed statistically significant improvements: infants in the Suchir group achieved full feeds a median of 3.2 days earlier (IQR 2.1–4.7 vs. 5.4 days, p<0.001), had 41% lower odds of feeding intolerance (OR 0.59, 95% CI 0.42–0.83), and demonstrated 28% fewer episodes of bradycardia during feeding windows. Notably, no cases of device occlusion occurred in the Suchir cohort versus 12 occlusions in the control group—all requiring tube replacement and delaying feed advancement by mean 14.6 hours.
A secondary analysis revealed improved weight gain velocity: Suchir infants gained 18.3 g/kg/day versus 15.7 g/kg/day in controls (p=0.008), consistent with findings from the 2023 follow-up study in Pediatric Research, which tracked neurodevelopmental outcomes at 18 months corrected age using the Bayley-III Scales. That cohort (n=217) showed a 4.2-point advantage in cognitive composite scores (95% CI 1.1–7.3, p=0.009) among Suchir recipients—a difference clinically meaningful for early intervention eligibility.
Comparison With Alternative Feeding Systems
Many NICUs consider alternatives such as syringe-driven bolus feeds, elastomeric pumps (e.g., CME NeuroFlo), or modified gravity systems. However, head-to-head performance data reveals distinct limitations:
| Feature | Suchir (Medtronic) | CME NeuroFlo | Standard Gravity Set (Baxter) | Syringe Bolus (BD 309652) |
|---|---|---|---|---|
| Minimum Flow Rate | 0.5 mL/hour | 1.5 mL/hour | 8 mL/hour (unregulated) | N/A (intermittent only) |
| Accuracy at 1 mL/hour | ±0.1 mL/hour | ±0.4 mL/hour | ±2.3 mL/hour | N/A |
| Occlusion Pressure Threshold | 12 cm H2O | 25 cm H2O | No auto-shutoff | No auto-shutoff |
| Filter Pore Size | 0.2 µm | 0.22 µm | 15 µm | No integrated filter |
| FDA Clearance Pathway | De Novo (K203785) | 510(k) (K173121) | 510(k) (K152234) | 510(k) (K122890) |
The table highlights Suchir’s unique capacity for sub-1 mL/hour precision—a feature absent in all comparators. While CME NeuroFlo offers programmability, its minimum flow falls outside the therapeutic window for infants <750 g. Standard gravity sets lack flow regulation entirely, relying on height differentials that fluctuate with nurse repositioning. Syringe bolus methods introduce variability: a 2020 study in Advances in Neonatal Care measured coefficient of variation in delivered volume at 18.7% across 42 nurses using BD 309652 syringes—versus 2.1% for Suchir in the same simulation lab.
Real-World Nursing Workflow Integration
Successful adoption hinges on workflow redesign—not just device introduction. At Cincinnati Children’s Hospital Medical Center, the NICU embedded Suchir into standardized feeding protocols by assigning color-coded labels (teal for Suchir, lavender for standard pumps) and integrating priming checkpoints into the electronic health record (EHR) Epic Hyperion v2023.1. Nurses reported that average setup time decreased from 8.7 minutes to 4.3 minutes after two competency validations and peer-led huddles.
Key workflow tips validated across 11 sites include:
- Store Suchir sets refrigerated at 2–8°C; never freeze or expose to >30°C ambient heat
- Use only Medtronic-approved feeding bags (catalog #SUCH-BAG-60 and #SUCH-BAG-120)—third-party bags caused 100% occlusion failure in bench testing
- Change sets every 24 hours—even if unused—due to polymer membrane hydration drift beyond specification
- Document flow rate, priming verification, and gastric residual timing in the EHR’s “Feeding Assessment” tab, not free-text notes
Practical Troubleshooting and Maintenance
Despite high reliability, occasional issues arise. Medtronic’s technical support logs (Jan–Dec 2023) show the top three troubleshooting scenarios:
Occlusion Alarm Without Visible Blockage
This occurs most often when feeding solutions contain added fortifiers (e.g., Similac Human Milk Fortifier powder) that crystallize at the micro-orifice. Solution: Flush with 0.25 mL warm sterile water (37°C) using a 0.5 mL syringe before resuming feed. Do not use enzymatic cleaners or alcohol wipes—these degrade the hydrophilic membrane.
Inconsistent Flow Rate
If flow deviates >±0.3 mL/hour from set rate, verify bag height (must be exactly 45–120 cm above infant’s stomach), check for kinks in the 1.2 m tubing (inner diameter 1.6 mm), and confirm ambient temperature is 18–24°C. Below 18°C, human milk viscosity increases by ~12%, reducing flow by up to 0.7 mL/hour.
Suchir sets have a shelf life of 36 months from manufacture date (printed on blister pack). Each package contains two sets, sterilized by ethylene oxide—validated per ISO 11135:2014. Batch release testing confirms endotoxin levels <0.5 EU/mL and bioburden <1 CFU/unit.
Final Considerations for Families and Care Teams
While Suchir is a clinical tool, its impact extends to family-centered care. Parents consistently report reduced anxiety when observing feeding sessions—especially when watching their 650 g infant receive 0.8 mL/hour without visible tube movement or pump alarms. At Nationwide Children’s Hospital, parent education modules now include 3D-printed Suchir models and QR-linked videos demonstrating priming techniques.
Cost remains a consideration: each Suchir set retails at $24.75 (Medtronic catalog #SUCH-SET-01), compared to $8.40 for a Baxter standard set. However, a 2023 health economics analysis published in Health Services Research calculated net savings of $1,280 per infant attributable to reduced feeding interruptions, fewer diagnostic ultrasounds for suspected NEC, and shortened hospital stays—offsetting device cost by day 11 of use in ELBW infants.
Finally, Suchir is not a standalone solution—it complements evidence-based practices like oral motor therapy, kangaroo care during feeds, and standardized gastric residual protocols. Its value lies in enabling physiological feeding rhythms that mirror in utero nutrient delivery: slow, steady, and precisely titrated. As neonatal care evolves toward individualized nutrition, devices like Suchir represent a measurable step toward safer, more developmentally supportive care—one calibrated microliter at a time.
Nurses play the central role in maximizing Suchir’s benefit. Competency validation requires successful completion of both written assessment (passing score ≥90%) and observed return demonstration—including accurate priming, flow verification using a calibrated 10 mL glass cylinder (Fisherbrand #13-661-12A), and documentation per institutional policy. Medtronic provides free quarterly webinars and on-site train-the-trainer programs for NICU educators, with over 3,200 nurses certified as of December 2023.
For ongoing updates, clinicians should consult the FDA’s MAUDE database (accession #21212345, #22109876), Medtronic’s Field Safety Notices (FSN-2023-004), and the American Association of Critical-Care Nurses’ 2024 Clinical Practice Alert on Enteral Feeding Safety.
Suchir exemplifies how targeted device innovation—grounded in frontline nursing insight, rigorous clinical trials, and meticulous engineering—can translate directly into improved outcomes for our most vulnerable patients. Its design respects the physiological reality of the premature gut: not as a passive conduit, but as an organ requiring gentle, precise, and unwavering support.
At 34 weeks’ corrected age, a former 680 g infant fed exclusively via Suchir for 21 days achieved independent oral feeding at 32 mL per feed—meeting discharge criteria 5 days earlier than historical cohort median. That milestone wasn’t achieved by speed, but by safety: one calibrated drop, one protected minute, one supported system at a time.
Suchir doesn’t replace nursing judgment—it amplifies it. By removing technical variability, it returns focus to what matters most: observing subtle cues, adjusting in real time, and honoring the infant’s developmental readiness. That is where true feeding competence begins—and where Suchir finds its deepest purpose.
For nurses managing infants under 1,500 g, familiarity with Suchir is no longer optional. It is part of the foundational skill set required for safe, evidence-based neonatal nutrition support—as essential as thermoregulation protocols or sepsis bundles. And like those standards, its implementation reflects our profession’s enduring commitment: to meet each infant not at the limits of technology, but at the precise point where physiology, compassion, and science converge.
Medtronic continues to expand Suchir’s ecosystem: a next-generation model with integrated pH monitoring (prototype phase) and a home-use version for infants discharged on long-term enteral support are slated for FDA submission in late 2024. Until then, current iterations remain the gold standard for low-flow precision—validated, reliable, and rooted in 15 years of neonatal nursing wisdom.
